Transfusion Medicine Reviews
Volume 21, Issue 3 , Pages 223-236 , July 2007

The Evidence for the Use of Recombinant Human Activated Factor VII in the Treatment of Bleeding Patients With Quantitative and Qualitative Platelet Disorders

  • Man-Chiu Poon

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Man-Chiu Poon, MD, University of Calgary, Foothills Hospital, 1403-29th St NW, Calgary, Alberta, Canada, T2N 2T9.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0887-7963(07)00019-3

doi: 10.1016/j.tmrv.2007.03.003

Transfusion Medicine Reviews
Volume 21, Issue 3 , Pages 223-236 , July 2007

Article Tools

* Image Usage & Resolution